| Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines SHT Jorritsma, EJ Gowans, B Grubor-Bauk, DK Wijesundara Vaccine 34 (46), 5488-5494, 2016 | 126 | 2016 |
| IL-4 and IL-13 receptors: Roles in immunity and powerful vaccine adjuvants C Ranasinghe, S Trivedi, DK Wijesundara, RJ Jackson Cytokine & growth factor reviews 25 (4), 437-442, 2014 | 100 | 2014 |
| Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial KJ Chappell, FL Mordant, Z Li, DK Wijesundara, P Ellenberg, ... The Lancet Infectious Diseases 21 (10), 1383-1394, 2021 | 98 | 2021 |
| SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein EA Albornoz, AA Amarilla, N Modhiran, S Parker, XX Li, DK Wijesundara, ... Molecular psychiatry 28 (7), 2878-2893, 2023 | 75 | 2023 |
| NS1 DNA vaccination protects against Zika infection through T cell–mediated immunity in immunocompetent mice B Grubor-Bauk, DK Wijesundara, M Masavuli, P Abbink, RL Peterson, ... Science advances 5 (12), eaax2388, 2019 | 64 | 2019 |
| Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2 D Watterson, DK Wijesundara, N Modhiran, FL Mordant, Z Li, ... Clinical & translational immunology 10 (4), e1269, 2021 | 53 | 2021 |
| Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery D Christiansen, L Earnest-Silveira, B Grubor-Bauk, DK Wijesundara, I Boo, ... Scientific reports 9 (1), 9251, 2019 | 52 | 2019 |
| Human immunodeficiency virus‐1 vaccine design: where do we go now? DK Wijesundara, RJ Jackson, IA Ramshaw, C Ranasinghe Immunology and cell biology 89 (3), 367-374, 2011 | 43 | 2011 |
| Preclinical development and production of virus-like particles as vaccine candidates for hepatitis C MG Masavuli, DK Wijesundara, J Torresi, EJ Gowans, B Grubor-Bauk Frontiers in microbiology 8, 306782, 2017 | 37 | 2017 |
| A hepatitis C virus DNA vaccine encoding a secreted, oligomerized form of envelope proteins is highly immunogenic and elicits neutralizing antibodies in vaccinated mice MG Masavuli, DK Wijesundara, A Underwood, D Christiansen, ... Frontiers in Immunology 10, 1145, 2019 | 32 | 2019 |
| Intradermal delivery of DNA encoding HCV NS3 and perforin elicits robust cell-mediated immunity in mice and pigs B Grubor-Bauk, W Yu, D Wijesundara, J Gummow, T Garrod, AJ Brennan, ... Gene therapy 23 (1), 26-37, 2016 | 32 | 2016 |
| Reduced Interleukin-4 Receptor α Expression on CD8+ T Cells Correlates with Higher Quality Anti-Viral Immunity DK Wijesundara, DC Tscharke, RJ Jackson, C Ranasinghe PLoS One 8 (1), e55788, 2013 | 32 | 2013 |
| A multiantigenic DNA vaccine that induces broad hepatitis C virus-specific T-cell responses in mice J Gummow, Y Li, W Yu, T Garrod, D Wijesundara, AJ Brennan, R Mullick, ... Journal of virology 89 (15), 7991-8002, 2015 | 31 | 2015 |
| Fluorescent target array killing assay: A multiplex cytotoxic T‐cell assay to measure detailed T‐cell antigen specificity and avidity in vivo BJC Quah, DK Wijesundara, C Ranasinghe, CR Parish Cytometry Part A 81 (8), 679-690, 2012 | 27 | 2012 |
| Fluorescent target array T helper assay: a multiplex flow cytometry assay to measure antigen-specific CD4+ T cell-mediated B cell help in vivo BJC Quah, DK Wijesundara, C Ranasinghe, CR Parish Journal of immunological methods 387 (1-2), 181-190, 2013 | 24 | 2013 |
| Viral vector and route of administration determine the ILC and DC profiles responsible for downstream vaccine-specific immune outcomes S Roy, MI Jaeson, Z Li, S Mahboob, RJ Jackson, B Grubor-Bauk, ... Vaccine 37 (10), 1266-1276, 2019 | 23 | 2019 |
| Induction of genotype cross-reactive, hepatitis C virus-specific, cell-mediated immunity in DNA-vaccinated mice DK Wijesundara, J Gummow, Y Li, W Yu, BJ Quah, C Ranasinghe, ... Journal of virology 92 (8), 10.1128/jvi. 02133-17, 2018 | 23 | 2018 |
| Use of an in vivo FTA assay to assess the magnitude, functional avidity and epitope variant cross-reactivity of T cell responses following HIV-1 recombinant poxvirus vaccination DK Wijesundara, C Ranasinghe, RJ Jackson, BA Lidbury, CR Parish, ... PloS one 9 (8), e105366, 2014 | 23 | 2014 |
| IL-4 and IL-13 mediated down-regulation of CD8 expression levels can dampen anti-viral CD8+ T cell avidity following HIV-1 recombinant pox viral vaccination DK Wijesundara, RJ Jackson, DC Tscharke, C Ranasinghe Vaccine 31 (41), 4548-4555, 2013 | 21 | 2013 |
| Immunological memory in imiquimod-induced murine model of psoriasiform dermatitis K Fenix, DK Wijesundara, AJ Cowin, B Grubor-Bauk, Z Kopecki International Journal of Molecular Sciences 21 (19), 7228, 2020 | 19 | 2020 |
